SIMILAR PATTERNS OF AMINO ACIDS FOR 5N5K_A_HAEA306

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bud PROTEIN (ACUTOLYSIN
A)

(Deinagkistrodon
acutus) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 800 (-3.2A)
ZN  A 800 ( 4.7A)
ZN  A 800 (-3.3A)
ZN  A 800 (-3.3A)
 0.24A 5n5kA-1budA:
11.1		 5n5kA-1budA:
21.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1fbl FIBROBLAST
(INTERSTITIAL)
COLLAGENASE (MMP-1)

(Sus scrofa) 		PF00045
(Hemopexin)
PF00413
(Peptidase_M10) 		4 HIS A 218
GLU A 219
HIS A 222
HIS A 228
 ZN  A 998 ( 3.5A)
HTA  A 900 (-3.0A)
ZN  A 998 ( 3.8A)
ZN  A 998 ( 3.6A)
 0.46A 5n5kA-1fblA:
27.4		 5n5kA-1fblA:
36.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h71 SERRALYSIN

(Pseudomonas sp.
'TAC II 18') 		PF00413
(Peptidase_M10)
PF08548
(Peptidase_M10_C) 		4 HIS P 169
GLU P 170
HIS P 173
HIS P 179
 ZN  P 600 (-3.4A)
ZN  P 600 ( 4.0A)
ZN  P 600 (-3.4A)
ZN  P 600 (-3.4A)
 0.30A 5n5kA-1h71P:
12.5		 5n5kA-1h71P:
17.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hfs STROMELYSIN-1

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 201
GLU A 202
HIS A 205
HIS A 211
 ZN  A 257 ( 3.1A)
L04  A 256 ( 2.7A)
ZN  A 257 ( 3.2A)
ZN  A 257 ( 3.1A)
 0.22A 5n5kA-1hfsA:
29.6		 5n5kA-1hfsA:
58.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hmd HEMERYTHRIN

(Themiste
dyscritum) 		no annotation 4 ILE A  21
HIS A  73
HIS A  77
HIS A 101
 None
FEO  A 115 (-3.4A)
FEO  A 115 (-3.4A)
FEO  A 115 (-3.4A)
 1.00A 5n5kA-1hmdA:
undetectable		 5n5kA-1hmdA:
18.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hmd HEMERYTHRIN

(Themiste
dyscritum) 		no annotation 4 ILE A  21
HIS A  77
HIS A 101
HIS A  73
 None
FEO  A 115 (-3.4A)
FEO  A 115 (-3.4A)
FEO  A 115 (-3.4A)
 0.75A 5n5kA-1hmdA:
undetectable		 5n5kA-1hmdA:
18.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hmd HEMERYTHRIN

(Themiste
dyscritum) 		no annotation 4 ILE A  21
HIS A 101
HIS A  73
HIS A  77
 None
FEO  A 115 (-3.4A)
FEO  A 115 (-3.4A)
FEO  A 115 (-3.4A)
 0.92A 5n5kA-1hmdA:
undetectable		 5n5kA-1hmdA:
18.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1htd ATROLYSIN C

(Crotalus atrox) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 401 ( 3.2A)
ZN  A 401 ( 4.5A)
ZN  A 401 ( 3.2A)
ZN  A 401 ( 3.2A)
 0.18A 5n5kA-1htdA:
11.5		 5n5kA-1htdA:
23.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1hv5 STROMELYSIN 3

(Mus musculus) 		PF00413
(Peptidase_M10) 		5 ILE A 180
HIS A 219
GLU A 220
HIS A 223
HIS A 229
 RXP  A6001 ( 3.8A)
ZN  A5502 ( 3.4A)
RXP  A6001 (-3.0A)
ZN  A5502 (-3.4A)
ZN  A5502 (-3.5A)
 0.42A 5n5kA-1hv5A:
24.6		 5n5kA-1hv5A:
49.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1iab ASTACIN

(Astacus astacus) 		PF01400
(Astacin) 		4 HIS A  92
GLU A  93
HIS A  96
HIS A 102
 CO  A 999 (-3.2A)
CO  A 999 ( 4.3A)
CO  A 999 (-3.3A)
CO  A 999 (-3.1A)
 0.24A 5n5kA-1iabA:
10.4		 5n5kA-1iabA:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kug METALLOPROTEINASE

(Protobothrops
mucrosquamatus) 		PF01421
(Reprolysin) 		4 HIS A 144
GLU A 145
HIS A 148
HIS A 154
 CD  A 981 (-3.5A)
CD  A 981 ( 4.6A)
CD  A 981 (-3.4A)
CD  A 981 (-3.4A)
 0.24A 5n5kA-1kugA:
11.2		 5n5kA-1kugA:
23.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1l6j MATRIX
METALLOPROTEINASE-9

(Homo sapiens) 		PF00040
(fn2)
PF00413
(Peptidase_M10)
PF01471
(PG_binding_1) 		4 HIS A 401
GLU A 402
HIS A 405
HIS A 411
 ZN  A 500 (-3.4A)
ZN  A 500 ( 4.3A)
ZN  A 500 (-3.2A)
ZN  A 500 (-3.4A)
 0.23A 5n5kA-1l6jA:
25.0		 5n5kA-1l6jA:
20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lml LEISHMANOLYSIN

(Leishmania
major) 		PF01457
(Peptidase_M8) 		4 HIS A 264
GLU A 265
HIS A 268
HIS A 334
 ZN  A 578 ( 3.5A)
ZN  A 578 ( 4.1A)
ZN  A 578 ( 3.4A)
ZN  A 578 ( 3.4A)
 0.43A 5n5kA-1lmlA:
8.6		 5n5kA-1lmlA:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nd1 BAP1

(Bothrops asper) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 400 (-3.2A)
ZN  A 400 ( 4.4A)
ZN  A 400 (-3.3A)
ZN  A 400 (-3.2A)
 0.12A 5n5kA-1nd1A:
11.3		 5n5kA-1nd1A:
25.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1qib 72 KDA TYPE IV
COLLAGENASE

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 201
GLU A 202
HIS A 205
HIS A 211
 ZN  A 501 (-3.5A)
ZN  A 501 ( 4.5A)
ZN  A 501 (-3.5A)
ZN  A 501 (-3.5A)
 0.32A 5n5kA-1qibA:
27.3		 5n5kA-1qibA:
58.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qua ACUTOLYSIN-C

(Deinagkistrodon
acutus) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 999 (-3.2A)
ZN  A 999 ( 4.5A)
ZN  A 999 (-3.3A)
ZN  A 999 (-3.1A)
 0.12A 5n5kA-1quaA:
11.4		 5n5kA-1quaA:
24.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r55 ADAM 33

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 345
GLU A 346
HIS A 349
HIS A 355
 ZN  A 201 ( 3.3A)
097  A 518 (-2.9A)
ZN  A 201 ( 3.2A)
ZN  A 201 ( 3.3A)
 0.30A 5n5kA-1r55A:
10.3		 5n5kA-1r55A:
25.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1rm8 MATRIX
METALLOPROTEINASE-16

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 246
GLU A 247
HIS A 250
HIS A 256
 ZN  A 500 ( 3.3A)
BAT  A 800 (-2.7A)
ZN  A 500 ( 3.2A)
ZN  A 500 ( 3.3A)
 0.16A 5n5kA-1rm8A:
27.8		 5n5kA-1rm8A:
50.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1slm STROMELYSIN-1

(Homo sapiens) 		PF00413
(Peptidase_M10)
PF01471
(PG_binding_1) 		4 HIS A 201
GLU A 202
HIS A 205
HIS A 211
 ZN  A 257 ( 3.0A)
ZN  A 257 ( 4.1A)
ZN  A 257 ( 3.2A)
ZN  A 257 ( 3.1A)
 0.19A 5n5kA-1slmA:
28.6		 5n5kA-1slmA:
40.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wni TRIMERELYSIN II

(Protobothrops
flavoviridis) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 999 (-3.5A)
ZN  A 999 ( 4.2A)
ZN  A 999 (-3.5A)
ZN  A 999 (-3.4A)
 0.18A 5n5kA-1wniA:
11.4		 5n5kA-1wniA:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xcr HYPOTHETICAL PROTEIN
PTD012

(Homo sapiens) 		PF08925
(DUF1907) 		4 HIS A 268
GLU A 110
HIS A 278
HIS A 266
 ZN  A1001 ( 3.2A)
ACY  A2001 ( 3.7A)
ZN  A1001 ( 3.2A)
ZN  A1001 ( 3.2A)
 0.95A 5n5kA-1xcrA:
undetectable		 5n5kA-1xcrA:
18.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xv2 HYPOTHETICAL
PROTEIN, SIMILAR TO
ALPHA-ACETOLACTATE
DECARBOXYLASE

(Staphylococcus
aureus) 		PF03306
(AAL_decarboxy) 		4 HIS A 175
GLU A  45
HIS A 186
HIS A 173
 ZN  A 801 (-3.4A)
ZN  A 801 ( 4.4A)
ZN  A 801 (-3.3A)
ZN  A 801 (-3.5A)
 0.75A 5n5kA-1xv2A:
undetectable		 5n5kA-1xv2A:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y13 6-PYRUVOYL
TETRAHYDROPTERIN
SYNTHASE

(Plasmodium
falciparum) 		PF01242
(PTPS) 		4 HIS A  41
GLU A  38
HIS A  29
HIS A  43
 ZN  A 174 ( 3.3A)
BIO  A 175 (-2.6A)
ZN  A 174 ( 3.5A)
ZN  A 174 ( 3.4A)
 0.92A 5n5kA-1y13A:
undetectable		 5n5kA-1y13A:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yp1 FII

(Deinagkistrodon
acutus) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 999 (-3.3A)
ZN  A 999 ( 4.9A)
ZN  A 999 (-3.4A)
ZN  A 999 (-3.2A)
 0.27A 5n5kA-1yp1A:
11.5		 5n5kA-1yp1A:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zoi ESTERASE

(Pseudomonas
putida) 		PF00561
(Abhydrolase_1) 		4 ILE A  12
GLU A 102
HIS A  28
HIS A  26
 None
 1.01A 5n5kA-1zoiA:
undetectable		 5n5kA-1zoiA:
20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zx5 MANNOSEPHOSPHATE
ISOMERASE, PUTATIVE

(Archaeoglobus
fulgidus) 		PF01238
(PMI_typeI) 		4 ILE A  89
HIS A 175
HIS A 100
HIS A  98
 ACY  A 506 ( 4.7A)
GOL  A 700 (-4.1A)
GOL  A 700 (-4.5A)
GOL  A 700 ( 4.2A)
 1.03A 5n5kA-1zx5A:
undetectable		 5n5kA-1zx5A:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a0s 6-PYRUVOYL
TETRAHYDROPTERIN
SYNTHASE

(Plasmodium
vivax) 		PF01242
(PTPS) 		4 HIS A  48
GLU A  45
HIS A  36
HIS A  50
 ZN  A 281 (-3.3A)
BIO  A 282 (-3.1A)
ZN  A 281 ( 3.5A)
ZN  A 281 (-3.3A)
 0.91A 5n5kA-2a0sA:
undetectable		 5n5kA-2a0sA:
19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2awc HEMERYTHRIN-LIKE
DOMAIN PROTEIN DCRH

(Desulfovibrio
vulgaris) 		PF01814
(Hemerythrin) 		4 ILE A  19
HIS A  78
HIS A  82
HIS A 118
 None
FEO  A 137 (-3.5A)
FEO  A 137 (-3.3A)
FEO  A 137 (-3.3A)
 0.91A 5n5kA-2awcA:
undetectable		 5n5kA-2awcA:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2awc HEMERYTHRIN-LIKE
DOMAIN PROTEIN DCRH

(Desulfovibrio
vulgaris) 		PF01814
(Hemerythrin) 		4 ILE A  19
HIS A  82
HIS A 118
HIS A  78
 None
FEO  A 137 (-3.3A)
FEO  A 137 (-3.3A)
FEO  A 137 (-3.5A)
 0.83A 5n5kA-2awcA:
undetectable		 5n5kA-2awcA:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2awc HEMERYTHRIN-LIKE
DOMAIN PROTEIN DCRH

(Desulfovibrio
vulgaris) 		PF01814
(Hemerythrin) 		4 ILE A  19
HIS A 118
HIS A  78
HIS A  82
 None
FEO  A 137 (-3.3A)
FEO  A 137 (-3.5A)
FEO  A 137 (-3.3A)
 0.84A 5n5kA-2awcA:
undetectable		 5n5kA-2awcA:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dw1 CATROCOLLASTATIN

(Crotalus atrox) 		PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		4 HIS A 333
GLU A 334
HIS A 337
HIS A 343
 ZN  A 700 ( 3.4A)
GM6  A   2 (-2.5A)
ZN  A 700 ( 3.2A)
ZN  A 700 ( 3.2A)
 0.23A 5n5kA-2dw1A:
10.6		 5n5kA-2dw1A:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e3x COAGULATION FACTOR
X-ACTIVATING ENZYME
HEAVY CHAIN

(Daboia
siamensis) 		PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		4 HIS A 145
GLU A 146
HIS A 149
HIS A 155
 ZN  A 800 ( 3.3A)
GM6  A 700 ( 3.4A)
ZN  A 800 ( 3.2A)
ZN  A 800 ( 3.1A)
 0.25A 5n5kA-2e3xA:
10.6		 5n5kA-2e3xA:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2erq VASCULAR
APOPTOSIS-INDUCING
PROTEIN 1

(Crotalus atrox) 		PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		4 HIS A 335
GLU A 336
HIS A 339
HIS A 345
 ZN  A 700 (-3.4A)
ZN  A 700 ( 4.3A)
ZN  A 700 (-3.4A)
ZN  A 700 (-3.0A)
 0.13A 5n5kA-2erqA:
10.2		 5n5kA-2erqA:
16.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fv5 ADAM 17

(Homo sapiens) 		PF13688
(Reprolysin_5) 		4 HIS A 405
GLU A 406
HIS A 409
HIS A 415
 ZN  A   3 ( 3.2A)
541  A   1 (-2.6A)
ZN  A   3 ( 3.3A)
ZN  A   3 ( 3.2A)
 0.25A 5n5kA-2fv5A:
10.0		 5n5kA-2fv5A:
24.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2jsd MATRIX
METALLOPROTEINASE-20

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 226
GLU A 227
HIS A 230
HIS A 236
 NGH  A 277 ( 3.0A)
NGH  A 277 (-3.6A)
ZN  A 276 ( 3.3A)
ZN  A 276 ( 3.0A)
 0.62A 5n5kA-2jsdA:
24.9		 5n5kA-2jsdA:
53.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2oy4 NEUTROPHIL
COLLAGENASE

(Homo sapiens) 		PF00413
(Peptidase_M10) 		5 ILE A 159
HIS A 197
GLU A 198
HIS A 201
HIS A 207
 None
ZN  A 999 (-3.2A)
ZN  A 999 ( 4.4A)
ZN  A 999 (-3.4A)
ZN  A 999 (-3.2A)
 0.56A 5n5kA-2oy4A:
29.1		 5n5kA-2oy4A:
53.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rjq ADAMTS-5

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 410
GLU A 411
HIS A 414
HIS A 420
 ZN  A   1 ( 3.2A)
BAT  A 559 (-2.5A)
ZN  A   1 ( 3.3A)
ZN  A   1 ( 3.3A)
 0.15A 5n5kA-2rjqA:
10.6		 5n5kA-2rjqA:
16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vqa SLL1358 PROTEIN

(Synechocystis
sp. PCC 6803) 		PF00190
(Cupin_1) 		4 ILE A 272
HIS A 283
HIS A 329
HIS A 285
 None
MN  A1006 ( 3.4A)
MN  A1006 (-3.5A)
MN  A1006 ( 3.5A)
 0.94A 5n5kA-2vqaA:
undetectable		 5n5kA-2vqaA:
17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vqa SLL1358 PROTEIN

(Synechocystis
sp. PCC 6803) 		PF00190
(Cupin_1) 		5 ILE A 272
HIS A 329
GLU A 290
HIS A 285
HIS A 283
 None
MN  A1006 (-3.5A)
MN  A1006 ( 2.3A)
MN  A1006 ( 3.5A)
MN  A1006 ( 3.4A)
 1.05A 5n5kA-2vqaA:
undetectable		 5n5kA-2vqaA:
17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x7m ARCHAEMETZINCIN

(Methanopyrus
kandleri) 		PF07998
(Peptidase_M54) 		4 HIS A 125
GLU A 126
HIS A 129
HIS A 135
 ZN  A1174 (-3.2A)
ZN  A1174 ( 4.2A)
ZN  A1174 (-3.2A)
ZN  A1174 (-3.2A)
 0.14A 5n5kA-2x7mA:
10.6		 5n5kA-2x7mA:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2y0o PROBABLE D-LYXOSE
KETOL-ISOMERASE

(Bacillus
subtilis) 		no annotation 4 HIS A 137
GLU A  82
HIS A  71
HIS A  69
 ZN  A1173 (-3.4A)
ZN  A1173 (-2.6A)
ZN  A1173 (-3.4A)
ZN  A1173 (-3.6A)
 1.02A 5n5kA-2y0oA:
undetectable		 5n5kA-2y0oA:
20.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2y6c MATRILYSIN

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 219
GLU A 220
HIS A 223
HIS A 229
 ZN  A1267 ( 3.2A)
TQI  A1269 (-2.9A)
ZN  A1267 ( 3.3A)
ZN  A1267 ( 3.2A)
 0.20A 5n5kA-2y6cA:
25.9		 5n5kA-2y6cA:
56.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b8z PROTEIN ADAMTS-5

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 410
GLU A 411
HIS A 414
HIS A 420
 ZN  A 901 ( 3.2A)
294  A 801 (-2.7A)
ZN  A 901 ( 3.3A)
ZN  A 901 ( 3.3A)
 0.14A 5n5kA-3b8zA:
10.9		 5n5kA-3b8zA:
24.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ba0 MACROPHAGE
METALLOELASTASE

(Homo sapiens) 		PF00045
(Hemopexin)
PF00413
(Peptidase_M10) 		5 ILE A 180
HIS A 218
GLU A 219
HIS A 222
HIS A 228
 None
ZN  A 471 (-4.0A)
ZN  A 471 ( 3.2A)
HAE  A 477 ( 3.1A)
ZN  A 471 (-3.7A)
 0.73A 5n5kA-3ba0A:
28.0		 5n5kA-3ba0A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bu7 GENTISATE
1,2-DIOXYGENASE

(Ruegeria
pomeroyi) 		PF07883
(Cupin_2) 		4 ILE A 258
HIS A 290
HIS A 330
HIS A 292
 None
FE2  A 500 (-3.5A)
FE2  A 500 (-3.4A)
FE2  A 500 (-3.5A)
 0.82A 5n5kA-3bu7A:
undetectable		 5n5kA-3bu7A:
18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3cny INOSITOL CATABOLISM
PROTEIN IOLE

(Lactobacillus
plantarum) 		PF01261
(AP_endonuc_2) 		4 ILE A  16
HIS A 159
HIS A 161
HIS A 192
 None
 0.90A 5n5kA-3cnyA:
undetectable		 5n5kA-3cnyA:
19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dsl ZINC
METALLOPROTEINASE-DI
SINTEGRIN
BOTHROPASIN

(Bothrops
jararaca) 		PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		4 HIS A 145
GLU A 146
HIS A 149
HIS A 155
 ZN  A 503 ( 3.3A)
TRP  A 505 (-2.4A)
ZN  A 503 ( 3.3A)
ZN  A 503 ( 3.3A)
 0.33A 5n5kA-3dslA:
10.1		 5n5kA-3dslA:
16.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3edi TOLLOID-LIKE PROTEIN
1

(Homo sapiens) 		PF01400
(Astacin) 		4 HIS A  92
GLU A  93
HIS A  96
HIS A 102
 ZN  A 210 (-3.2A)
ZN  A 210 ( 4.3A)
ZN  A 210 (-3.3A)
ZN  A 210 (-3.2A)
 0.14A 5n5kA-3ediA:
9.9		 5n5kA-3ediA:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eqe PUTATIVE CYSTEIN
DIOXYGENASE

(Bacillus
subtilis) 		PF05995
(CDO_I) 		4 ILE A  64
HIS A  77
HIS A  75
HIS A 125
 None
FE  A 202 (-3.6A)
FE  A 202 (-3.5A)
FE  A 202 (-3.5A)
 0.84A 5n5kA-3eqeA:
undetectable		 5n5kA-3eqeA:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eqe PUTATIVE CYSTEIN
DIOXYGENASE

(Bacillus
subtilis) 		PF05995
(CDO_I) 		4 ILE A  64
HIS A 125
HIS A  77
HIS A  75
 None
FE  A 202 (-3.5A)
FE  A 202 (-3.6A)
FE  A 202 (-3.5A)
 0.93A 5n5kA-3eqeA:
undetectable		 5n5kA-3eqeA:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gbo ZINC
METALLOPROTEINASE
BMOOMPALFA-I

(Bothrops
moojeni) 		PF01421
(Reprolysin) 		4 HIS A 140
GLU A 141
HIS A 144
HIS A 150
 ZN  A 302 (-3.3A)
ZN  A 302 ( 4.6A)
ZN  A 302 (-3.3A)
ZN  A 302 (-3.2A)
 0.23A 5n5kA-3gboA:
11.1		 5n5kA-3gboA:
25.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h0g DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB11
DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB2
DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB3

(Schizosaccharomyces
pombe) 		PF00562
(RNA_pol_Rpb2_6)
PF01000
(RNA_pol_A_bac)
PF01193
(RNA_pol_L)
PF04560
(RNA_pol_Rpb2_7)
PF04561
(RNA_pol_Rpb2_2)
PF04563
(RNA_pol_Rpb2_1)
PF04565
(RNA_pol_Rpb2_3)
PF04566
(RNA_pol_Rpb2_4)
PF04567
(RNA_pol_Rpb2_5)
PF13656
(RNA_pol_L_2) 		4 ILE C 164
HIS K  39
GLU B 986
HIS K  68
 None
 1.02A 5n5kA-3h0gC:
undetectable		 5n5kA-3h0gC:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hdb AAHIV

(Deinagkistrodon
acutus) 		PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		5 ILE A 298
HIS A 333
GLU A 334
HIS A 337
HIS A 343
 None
ZN  A 620 (-3.4A)
ZN  A 620 ( 4.2A)
ZN  A 620 (-3.3A)
ZN  A 620 (-3.1A)
 0.59A 5n5kA-3hdbA:
10.5		 5n5kA-3hdbA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k7n K-LIKE

(Naja atra) 		PF01421
(Reprolysin)
PF08516
(ADAM_CR) 		4 HIS A 341
GLU A 342
HIS A 345
HIS A 351
 ZN  A 704 (-3.1A)
ZN  A 704 ( 4.5A)
ZN  A 704 (-3.3A)
ZN  A 704 (-3.2A)
 0.18A 5n5kA-3k7nA:
10.8		 5n5kA-3k7nA:
18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kmh D-LYXOSE ISOMERASE

(Escherichia
coli) 		PF07385
(Lyx_isomer) 		4 HIS A 171
GLU A 110
HIS A 105
HIS A 103
 MN  A1001 (-3.3A)
MN  A1001 (-2.6A)
MN  A1001 (-3.2A)
MN  A1001 (-3.6A)
 1.02A 5n5kA-3kmhA:
undetectable		 5n5kA-3kmhA:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lmc PEPTIDASE,
ZINC-DEPENDENT

(Methanocorpusculum
labreanum) 		PF07998
(Peptidase_M54) 		4 HIS A 149
GLU A 150
HIS A 153
HIS A 159
 ZN  A 212 (-3.4A)
ZN  A 212 ( 4.3A)
ZN  A 212 (-3.4A)
ZN  A 212 (-3.3A)
 0.22A 5n5kA-3lmcA:
8.3		 5n5kA-3lmcA:
26.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lot UNCHARACTERIZED
PROTEIN

(Archaeoglobus
fulgidus) 		PF05853
(BKACE) 		4 ILE A 201
HIS A  49
GLU A 261
HIS A  51
 UNL  A 503 ( 4.4A)
ZN  A 501 (-3.4A)
ZN  A 501 (-2.7A)
ZN  A 501 (-3.4A)
 1.02A 5n5kA-3lotA:
undetectable		 5n5kA-3lotA:
22.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lqb LOC792177 PROTEIN

(Danio rerio) 		PF01400
(Astacin) 		4 HIS A  99
GLU A 100
HIS A 103
HIS A 109
 ZN  A 201 ( 3.2A)
SO4  A 200 (-3.0A)
ZN  A 201 ( 3.3A)
ZN  A 201 ( 3.2A)
 0.23A 5n5kA-3lqbA:
10.3		 5n5kA-3lqbA:
22.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lun ULILYSIN

(Methanosarcina
acetivorans) 		PF05572
(Peptidase_M43) 		5 ILE A 187
HIS A 228
GLU A 229
HIS A 232
HIS A 238
 None
ZN  A 999 (-3.1A)
ZN  A 999 ( 3.8A)
ZN  A 999 (-3.1A)
ZN  A 999 (-3.0A)
 0.56A 5n5kA-3lunA:
8.7		 5n5kA-3lunA:
23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o14 ANTI-ECFSIGMA
FACTOR, CHRR

(Marinobacter
hydrocarbonoclasticus) 		PF12973
(Cupin_7) 		4 ILE A 104
HIS A  60
HIS A  58
HIS A  94
 None
ZN  A 250 (-3.3A)
ZN  A 250 (-3.3A)
ZN  A 250 (-3.3A)
 0.79A 5n5kA-3o14A:
undetectable		 5n5kA-3o14A:
20.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3o2x COLLAGENASE 3

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A1222
GLU A1223
HIS A1226
HIS A1232
 ZN  A1999 ( 3.2A)
3O2  A1801 (-2.7A)
ZN  A1999 ( 3.4A)
ZN  A1999 ( 3.2A)
 0.18A 5n5kA-3o2xA:
28.9		 5n5kA-3o2xA:
56.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3p24 BFT-3

(Bacteroides
fragilis) 		PF13583
(Reprolysin_4)
PF16376
(fragilysinNterm) 		5 ILE A 313
HIS A 348
GLU A 349
HIS A 352
HIS A 358
 None
ZN  A 999 (-3.2A)
ZN  A 999 ( 4.9A)
ZN  A 999 (-3.2A)
ZN  A 999 ( 3.2A)
 0.54A 5n5kA-3p24A:
8.7		 5n5kA-3p24A:
18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q2h A DISINTEGRIN AND
METALLOPROTEINASE
WITH THROMBOSPONDIN
MOTIFS 1

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 149
GLU A 150
HIS A 153
HIS A 159
 ZN  A 401 ( 3.3A)
QHF  A   1 (-2.6A)
QHF  A   1 ( 3.0A)
ZN  A 401 ( 3.2A)
 0.17A 5n5kA-3q2hA:
10.8		 5n5kA-3q2hA:
18.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rde ARACHIDONATE
12-LIPOXYGENASE,
12S-TYPE

(Sus scrofa) 		PF00305
(Lipoxygenase) 		4 ILE A 593
GLU A 357
HIS A 361
HIS A 545
 OYP  A 664 (-4.3A)
OYP  A 664 (-3.6A)
FE2  A   1 ( 3.4A)
FE2  A   1 (-3.3A)
 0.87A 5n5kA-3rdeA:
undetectable		 5n5kA-3rdeA:
15.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rys ADENOSINE DEAMINASE
1

(Paenarthrobacter
aurescens) 		PF00962
(A_deaminase) 		4 ILE A 139
HIS A  21
HIS A  19
HIS A 199
 None
ADE  A 345 ( 3.2A)
ZN  A 344 (-3.5A)
ZN  A 344 ( 3.4A)
 0.89A 5n5kA-3rysA:
undetectable		 5n5kA-3rysA:
19.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3shi INTERSTITIAL
COLLAGENASE

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 218
GLU A 219
HIS A 222
HIS A 228
 ZN  A 301 (-3.3A)
ZN  A 301 ( 4.7A)
ZN  A 301 (-3.4A)
ZN  A 301 (-3.3A)
 0.28A 5n5kA-3shiA:
29.6		 5n5kA-3shiA:
57.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3v96 STROMELYSIN-2

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS B 217
GLU B 218
HIS B 221
HIS B 227
 ZN  B 301 (-3.2A)
ZN  B 301 ( 3.9A)
ZN  B 301 (-3.3A)
ZN  B 301 (-3.2A)
 0.23A 5n5kA-3v96B:
30.0		 5n5kA-3v96B:
57.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vi1 ALKALINE
METALLOPROTEINASE

(Pseudomonas
aeruginosa) 		PF08548
(Peptidase_M10_C)
PF13583
(Reprolysin_4) 		4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
 ZN  A 500 (-3.2A)
ZN  A 500 ( 4.2A)
ZN  A 500 (-3.3A)
ZN  A 500 (-3.2A)
 0.16A 5n5kA-3vi1A:
12.8		 5n5kA-3vi1A:
16.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vtg HIGH CHORIOLYTIC
ENZYME 1

(Oryzias latipes) 		PF01400
(Astacin) 		4 HIS A  99
GLU A 100
HIS A 103
HIS A 109
 ZN  A 301 (-3.3A)
ZN  A 301 ( 4.3A)
ZN  A 301 (-3.3A)
ZN  A 301 (-3.2A)
 0.14A 5n5kA-3vtgA:
10.3		 5n5kA-3vtgA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a3w ARCHAEMETZINCIN

(Archaeoglobus
fulgidus) 		PF07998
(Peptidase_M54) 		4 HIS A 117
GLU A 118
HIS A 121
HIS A 127
 ZN  A1159 ( 3.2A)
FLC  A1161 (-2.9A)
ZN  A1159 ( 3.3A)
ZN  A1159 ( 3.2A)
 0.31A 5n5kA-4a3wA:
8.2		 5n5kA-4a3wA:
26.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aig ADAMALYSIN II

(Crotalus
adamanteus) 		PF01421
(Reprolysin) 		5 ILE A 107
HIS A 142
GLU A 143
HIS A 146
HIS A 152
 FLX  A 400 (-3.9A)
ZN  A 999 ( 3.2A)
FLX  A 400 (-2.8A)
ZN  A 999 ( 3.3A)
ZN  A 999 ( 3.5A)
 0.62A 5n5kA-4aigA:
11.3		 5n5kA-4aigA:
27.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bt6 ALPHA-ACETOLACTATE
DECARBOXYLASE

(Brevibacillus
brevis) 		PF03306
(AAL_decarboxy) 		4 HIS A 196
GLU A  65
HIS A 207
HIS A 194
 ZN  A1257 ( 3.3A)
GOL  A1258 (-2.7A)
ZN  A1257 ( 3.2A)
ZN  A1257 ( 3.3A)
 0.82A 5n5kA-4bt6A:
undetectable		 5n5kA-4bt6A:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dd8 DISINTEGRIN AND
METALLOPROTEINASE
DOMAIN-CONTAINING
PROTEIN 8

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 334
GLU A 335
HIS A 338
HIS A 344
 ZN  A1002 ( 3.3A)
BAT  A1000 (-2.7A)
ZN  A1002 (-3.3A)
ZN  A1002 ( 3.3A)
 0.40A 5n5kA-4dd8A:
10.4		 5n5kA-4dd8A:
21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dgq NON-HEME
CHLOROPEROXIDASE

(Burkholderia
cenocepacia) 		PF00561
(Abhydrolase_1) 		4 ILE A  12
GLU A 102
HIS A  28
HIS A  26
 None
 1.03A 5n5kA-4dgqA:
undetectable		 5n5kA-4dgqA:
19.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gr8 MACROPHAGE
METALLOELASTASE

(Homo sapiens) 		PF00413
(Peptidase_M10) 		5 ILE A 180
HIS A 218
GLU A 219
HIS A 222
HIS A 228
 R4C  A 306 (-4.3A)
R4C  A 306 ( 3.2A)
R4C  A 306 (-2.7A)
ZN  A 301 ( 3.2A)
ZN  A 301 ( 3.2A)
 0.27A 5n5kA-4gr8A:
30.2		 5n5kA-4gr8A:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gwn MEPRIN A SUBUNIT
BETA

(Homo sapiens) 		PF00629
(MAM)
PF01400
(Astacin) 		4 HIS A 152
GLU A 153
HIS A 156
HIS A 162
 CD  A 701 (-3.7A)
CD  A 701 (-3.5A)
CD  A 701 (-3.7A)
CD  A 701 (-3.7A)
 0.25A 5n5kA-4gwnA:
9.2		 5n5kA-4gwnA:
13.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4in9 KARILYSIN PROTEASE

(Tannerella
forsythia) 		PF00413
(Peptidase_M10) 		4 HIS A 155
GLU A 156
HIS A 159
HIS A 165
 ZN  A 301 (-3.2A)
ZN  A 301 ( 4.2A)
ZN  A 301 (-3.3A)
ZN  A 301 (-3.3A)
 0.16A 5n5kA-4in9A:
23.4		 5n5kA-4in9A:
40.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j4m ZINC-DEPENDENT
METALLOPROTEINASE

(Protobothrops
mucrosquamatus) 		PF01421
(Reprolysin) 		4 HIS A 144
GLU A 145
HIS A 148
HIS A 154
 ZN  A 301 (-3.3A)
ZN  A 301 ( 4.6A)
ZN  A 301 (-3.2A)
ZN  A 301 (-3.2A)
 0.14A 5n5kA-4j4mA:
11.4		 5n5kA-4j4mA:
24.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jiu PROABYLYSIN

(Pyrococcus
abyssi) 		PF01863
(DUF45) 		4 HIS A  60
GLU A  61
HIS A  64
HIS A  72
 ZN  A 201 (-3.2A)
ZN  A 201 ( 4.8A)
ZN  A 201 (-3.2A)
ZN  A 201 (-3.2A)
 0.40A 5n5kA-4jiuA:
4.7		 5n5kA-4jiuA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jix PROJANNALYSIN

(Methanocaldococcus
jannaschii) 		PF01863
(DUF45) 		4 HIS A  69
GLU A  70
HIS A  73
HIS A  81
 ZN  A 201 (-3.3A)
TRS  A 202 (-3.8A)
ZN  A 201 ( 3.3A)
ZN  A 201 (-3.3A)
 0.54A 5n5kA-4jixA:
4.7		 5n5kA-4jixA:
19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l63 ECXA

(Escherichia
coli) 		PF16313
(DUF4953) 		4 HIS A 179
GLU A 180
HIS A 183
HIS A 189
 ZN  A 301 (-3.3A)
ZN  A 301 ( 4.4A)
ZN  A 301 (-3.4A)
ZN  A 301 (-3.3A)
 0.15A 5n5kA-4l63A:
11.5		 5n5kA-4l63A:
22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q1l SNAKE VENOM
METALLOPROTEINASE
LEUCUROLYSIN-A

(Bothrops
leucurus) 		PF01421
(Reprolysin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 302 (-3.2A)
ZN  A 302 ( 4.7A)
ZN  A 302 (-3.1A)
ZN  A 302 (-3.1A)
 0.18A 5n5kA-4q1lA:
11.2		 5n5kA-4q1lA:
24.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qgn 1,2-DIHYDROXY-3-KETO
-5-METHYLTHIOPENTENE
DIOXYGENASE

(Homo sapiens) 		PF03079
(ARD) 		4 HIS A 133
GLU A  94
HIS A  90
HIS A  88
 FE  A 201 (-3.3A)
FE  A 201 ( 2.7A)
FE  A 201 (-3.3A)
FE  A 201 (-3.4A)
 1.02A 5n5kA-4qgnA:
undetectable		 5n5kA-4qgnA:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qhi UNCHARACTERIZED
PROTEIN MJ1213

(Methanocaldococcus
jannaschii) 		PF01435
(Peptidase_M48) 		4 HIS A  69
GLU A  70
HIS A  73
HIS A  80
 ZN  A 201 ( 3.2A)
GOL  A 202 (-3.1A)
ZN  A 201 ( 3.1A)
ZN  A 201 ( 3.2A)
 0.42A 5n5kA-4qhiA:
6.1		 5n5kA-4qhiA:
19.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wk7 A DISINTEGRIN AND
METALLOPROTEINASE
WITH THROMBOSPONDIN
MOTIFS 4

(Homo sapiens) 		PF01421
(Reprolysin) 		4 HIS A 361
GLU A 362
HIS A 365
HIS A 371
 ZN  A 501 ( 3.2A)
3PQ  A 505 (-2.6A)
ZN  A 501 ( 3.3A)
ZN  A 501 ( 3.2A)
 0.26A 5n5kA-4wk7A:
10.9		 5n5kA-4wk7A:
19.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xct MATRIX
METALLOPROTEINASE-9,
MATRIX
METALLOPROTEINASE-9

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 226
GLU A 227
HIS A 230
HIS A 236
 ZN  A 302 ( 3.2A)
N73  A 301 (-2.5A)
ZN  A 302 ( 3.3A)
ZN  A 302 ( 3.3A)
 0.10A 5n5kA-4xctA:
29.3		 5n5kA-4xctA:
50.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z11 AURONE SYNTHASE

(Coreopsis
grandiflora) 		PF00264
(Tyrosinase)
PF12142
(PPO1_DWL)
PF12143
(PPO1_KFDV) 		4 ILE A 115
HIS A 252
HIS A 256
HIS A 286
 None
CU  A 701 (-3.1A)
CU  A 701 (-3.1A)
CU  A 701 (-3.1A)
 1.02A 5n5kA-4z11A:
undetectable		 5n5kA-4z11A:
15.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5avp L-RIBOSE ISOMERASE

(Geodermatophilus
obscurus) 		no annotation 4 ILE A  69
HIS A 110
HIS A 192
HIS A 112
 None
MN  A 401 (-3.4A)
MN  A 401 (-3.5A)
MN  A 401 (-3.5A)
 0.99A 5n5kA-5avpA:
undetectable		 5n5kA-5avpA:
18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5czw MYROILYSIN

(Myroides
profundi) 		PF01400
(Astacin) 		4 HIS A 142
GLU A 143
HIS A 146
HIS A 152
 ZN  A 301 ( 3.4A)
ZN  A 301 ( 4.2A)
ZN  A 301 ( 3.3A)
ZN  A 301 ( 3.1A)
 0.30A 5n5kA-5czwA:
11.1		 5n5kA-5czwA:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d7w SERRALYSIN

(Serratia
marcescens) 		PF00353
(HemolysinCabind)
PF00413
(Peptidase_M10)
PF08548
(Peptidase_M10_C) 		4 HIS A 176
GLU A 177
HIS A 180
HIS A 186
 HIS  A 176 (-1.0A)
GLU  A 177 ( 0.6A)
HIS  A 180 (-1.0A)
HIS  A 186 (-1.0A)
 0.27A 5n5kA-5d7wA:
13.8		 5n5kA-5d7wA:
26.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5h0u MATRIX
METALLOPROTEINASE-14

(Homo sapiens) 		PF00413
(Peptidase_M10) 		4 HIS A 239
GLU A 240
HIS A 243
HIS A 249
 ZN  A 302 ( 3.3A)
GOL  A 311 (-4.2A)
ZN  A 302 (-3.4A)
ZN  A 302 (-3.2A)
 0.15A 5n5kA-5h0uA:
27.7		 5n5kA-5h0uA:
50.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jig UBIQUITIN AND WLM
DOMAIN-CONTAINING
METALLOPROTEASE
SPCC1442.07C

(Schizosaccharomyces
pombe) 		PF08325
(WLM) 		4 HIS A  97
GLU A  98
HIS A 101
HIS A 107
 NI  A 201 ( 3.3A)
OXY  A 202 (-2.8A)
NI  A 201 ( 3.3A)
NI  A 201 (-3.3A)
 0.34A 5n5kA-5jigA:
2.4		 5n5kA-5jigA:
21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lmc ANAEROBIC NITRIC
OXIDE REDUCTASE
FLAVORUBREDOXIN

(Escherichia
coli) 		PF00258
(Flavodoxin_1)
PF00301
(Rubredoxin)
PF00753
(Lactamase_B) 		4 ILE A 198
GLU A  81
HIS A  84
HIS A 227
 PO4  A 503 (-4.6A)
FEO  A 501 (-3.1A)
FEO  A 501 (-3.2A)
FEO  A 501 ( 3.3A)
 1.00A 5n5kA-5lmcA:
2.4		 5n5kA-5lmcA:
15.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5or4 CATECHOL OXIDASE

(Aspergillus
oryzae) 		no annotation 4 ILE A 109
HIS A 284
HIS A 288
HIS A 312
 None
CU  A2002 (-3.2A)
CU  A2002 (-3.2A)
CU  A2002 (-3.1A)
 0.99A 5n5kA-5or4A:
undetectable		 5n5kA-5or4A:
19.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5th6 MATRIX
METALLOPROTEINASE-9,
MATRIX
METALLOPROTEINASE-9

(Homo sapiens) 		PF00413
(Peptidase_M10)
PF01471
(PG_binding_1) 		4 HIS A 401
GLU A 402
HIS A 405
HIS A 411
 ZN  A 501 (-3.3A)
ZN  A 501 ( 4.2A)
ZN  A 501 (-3.2A)
ZN  A 501 (-3.1A)
 0.17A 5n5kA-5th6A:
25.0		 5n5kA-5th6A:
37.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wu7 UNCHARACTERIZED
PROTEIN

(Pyrococcus
horikoshii) 		PF03065
(Glyco_hydro_57)
PF09210
(DUF1957) 		4 ILE A 524
HIS A 489
GLU A 460
HIS A  19
 None
 0.92A 5n5kA-5wu7A:
undetectable		 5n5kA-5wu7A:
15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xbn WSS1P

(Saccharomyces
cerevisiae) 		no annotation 4 HIS A 115
GLU A 116
HIS A 119
HIS A 125
 ZN  A 201 (-3.2A)
ZN  A 201 ( 4.7A)
ZN  A 201 (-3.3A)
ZN  A 201 (-3.2A)
 0.28A 5n5kA-5xbnA:
5.0		 5n5kA-5xbnA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xne -

(-) 		no annotation 4 HIS B 193
GLU B  62
HIS B 204
HIS B 191
 ZN  B 301 (-3.4A)
ZN  B 301 ( 4.5A)
ZN  B 301 (-3.3A)
ZN  B 301 (-3.5A)
 0.80A 5n5kA-5xneB:
undetectable		 5n5kA-5xneB:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bdz DISINTEGRIN AND
METALLOPROTEINASE
DOMAIN-CONTAINING
PROTEIN 10

(Homo sapiens) 		no annotation 4 HIS A 383
GLU A 384
HIS A 387
HIS A 393
 ZN  A 705 (-3.3A)
ZN  A 705 (-3.8A)
ZN  A 705 (-4.0A)
ZN  A 705 (-3.2A)
 0.44A 5n5kA-6bdzA:
10.2		 5n5kA-6bdzA:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6btp -

(-) 		no annotation 4 HIS A  93
GLU A  94
HIS A  97
HIS A 103
 ZN  A 302 ( 3.3A)
E8J  A 304 (-2.6A)
ZN  A 302 ( 3.4A)
ZN  A 302 ( 3.3A)
 0.15A 5n5kA-6btpA:
9.7		 5n5kA-6btpA:
undetectable